Jennifer L. Vande Voort

Author

Mayo Clinic ORCID

Also Known As

J.L. Vande Voort, JENNIFER L. VANDE VOORT, Jennifer L Vande Voort, Jennifer L. Vande Voort, Jennifer L. VandeVoort

130

Publications

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed Mayo Clinic in Florida National Institute of Mental Health

About

Jennifer L. Vande Voort is an author at Mayo Clinic specializing in psychiatry, psychopathology, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	1.2K
2	Social Sciences	15	17	1.2K
3	Education	1	1	75
4	Public Health	1	1	222
5	Anesthesia	1	1	11

Jennifer L. Vande Voort

Publications

Citations

H-Index

Page 1

	Year	Citations
Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety Elizabeth D. Ballard, Dawn F. Ionescu, Jennifer L. Vande Voort, Journal of Psychiatric Research PsychopathologyPsychiatryMedicinePsychotropic MedicationSuicidal Ideation	2014	276
The PHQ-9 Item 9 based screening for suicide risk: a validation study of the Patient Health Questionnaire (PHQ)−9 Item 9 with the Columbia Suicide Severity Rating Scale (C-SSRS) Peter J. Na, Satyanarayana R. Yaramala, Jihoon Kim, Journal of Affective Disorders Psychological Co-morbiditiesPsychiatrySuicideClinical PsychologyDepression	2018	222
Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine Dawn F. Ionescu, David A. Luckenbaugh, Mark J. Niciu, The Journal of Clinical Psychiatry	2014	108
High-frequency repetitive TMS for suicidal ideation in adolescents with depression Paul E. Croarkin, Paul A. Nakonezny, Zhi‐De Deng, Journal of Affective Disorders PsychopathologyPsychiatryMood SymptomHigh-frequency Repetitive TmsSuicide	2018	98
Continuation phase intravenous ketamine in adults with treatment-resistant depression Jennifer L. Vande Voort, Robert J. Morgan, Simon Kung, Journal of Affective Disorders PsychiatryMedicinePsychotropic MedicationDepressionPsychopharmacology	2016	91
Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment Kathryn M. Schak, Jennifer L. Vande Voort, Emily K. Johnson, American Journal of Psychiatry PsychiatryDepression TreatmentMedicinePsychotropic MedicationMood Symptom	2016	90
Lymphocytic Duodenosis and the Spectrum of Celiac Disease Jennifer L. Vande Voort, Joseph A. Murray, Brian D. Lahr, The American Journal of Gastroenterology	2008	78
Impact of the DSM-5 Attention-Deficit/Hyperactivity Disorder Age-of-Onset Criterion in the US Adolescent Population Jennifer L. Vande Voort, Jian-Ping He, Nicole Jameson, Journal of the American Academy of Child & Adolescent Psychiatry AdhdNeuropsychological FunctioningPsychiatryAdolescent MedicinePediatrics	2014	75
Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant Elizabeth D. Ballard, David A. Luckenbaugh, Erica M. Richards, Journal of Psychiatric Research PsychiatryPsychotropic MedicationSuicidal IdeationSuicideClinical Trials	2015	68
Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder Jennifer L. Vande Voort, Elizabeth D. Ballard, David A Luckenbaugh, The Journal of Clinical Psychiatry	2016	64

Page 1